Ascorbic acid for treatment in CMT1A: what's next?
Lancet Neurol
.
2011 Apr;10(4):291-3.
doi: 10.1016/S1474-4422(11)70042-4.
Authors
Marianne de Visser
1
,
Camiel Verhamme
Affiliation
1
Department of Neurology, Academic Medical Centre, 1100 DD Amsterdam, Netherlands. m.devisser@amc.nl
PMID:
21393064
DOI:
10.1016/S1474-4422(11)70042-4
No abstract available
Publication types
Comment
MeSH terms
Ascorbic Acid / therapeutic use*
Charcot-Marie-Tooth Disease / drug therapy*
Humans
Treatment Outcome
Substances
Ascorbic Acid